Abciximab Intravenous and Insulin Degludec (U-100) Vials
Determining the interaction of Abciximab Intravenous and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abciximab
Brand name: ReoPro
Synonyms: Abciximab
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abciximab Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Abciximab Intravenous-Insulin degludec and liraglutide
- Abciximab Intravenous-Insulin degludec and liraglutide Subcutaneous
- Abciximab Intravenous-Insulin degludec Subcutaneous
- Abciximab Intravenous-Insulin detemir
- Abciximab Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-ABDEK
- Insulin Degludec (U-100) Vials-Abelcet
- Insulin Degludec (U-100) Vials-Abemaciclib
- Insulin Degludec (U-100) Vials-Abenol
- Insulin Degludec (U-100) Vials-Abilify
- Insulin Degludec (U-100) Vials-Abilify (Aripiprazole Injection)